Form 8-K - Current report:
SEC Accession No. 0001826466-24-000131
Filing Date
2024-10-16
Accepted
2024-10-16 12:53:03
Documents
16
Period of Report
2024-10-02
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form-8k.htm   iXBRL 8-K 12641
2 EXHIBIT 23-1 exhibit23-1.htm EX-23 1319
3 EXHIBIT 23-1 exhibit23-1x1x1.jpg GRAPHIC 8508
4 EXHIBIT 23-1 exhibit23-1x1x2.jpg GRAPHIC 1037
  Complete submission text file 0001826466-24-000131.txt   191749

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE nkph-20241002.xsd EX-101.SCH 3048
6 XBRL LABEL FILE nkph-20241002_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE nkph-20241002_pre.xml EX-101.PRE 22381
19 EXTRACTED XBRL INSTANCE DOCUMENT form-8k_htm.xml XML 3121
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

EIN.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56234 | Film No.: 241374026
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)